Abstract
The 49th Interscience Conference on Antimicrobial Agents and Chemotherapy further emphasised the need for new antibiotics to combat the escalating problem of bacterial resistance. In addition to previous microbial problems such as meticillin-resistant Staphylococcus aureus, the continued emergence of pan-resistant Gram-negative organisms provides further clinical difficulties. These organisms are now ubiquitous worldwide, so perhaps it is time to address this matter from an international perspective? Push and pull of antibiotic developmentLast month's summit between the European Union (EU) and the USA, in Washington, DC, saw US President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt—on behalf of the EU Presidency—agree to establish a transatlantic taskforce to tackle antibiotic resistance. The Infectious Disease Society of America (IDSA) subsequently wrote to the respective leaders commending them on their undertaking and advising that the prospective taskforce include an antibacterial drug pipeline work group. The letter called for global commitment to the development of new antibacterial drugs. Full-Text PDF
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
